These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7788948)

  • 1. Effects of treatment with lovastatin and pravastatin on daytime cognitive performance.
    Gengo F; Cwudzinski D; Kinkel P; Block G; Stauffer L; Lines C
    Clin Cardiol; 1995 Apr; 18(4):209-14. PubMed ID: 7788948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system effects of HMG CoA reductase inhibitors: lovastatin and pravastatin on sleep and cognitive performance in patients with hypercholesterolemia.
    Kostis JB; Rosen RC; Wilson AC
    J Clin Pharmacol; 1994 Oct; 34(10):989-96. PubMed ID: 7836550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lovastatin and pravastatin on cognitive function in military aircrew.
    Gibellato MG; Moore JL; Selby K; Bower EA
    Aviat Space Environ Med; 2001 Sep; 72(9):805-12. PubMed ID: 11565814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of effects on sleep of lovastatin and pravastatin in hypercholesterolemia.
    Partinen M; Pihl S; Strandberg T; Vanhanen H; Murtomäki E; Block G; Neafus R; Haigh J; Miettinen T; Reines S
    Am J Cardiol; 1994 May; 73(12):876-80. PubMed ID: 8184812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of treatment with simvastatin and pravastatin on cognitive function in patients with hypercholesterolaemia.
    Cutler N; Sramek J; Veroff A; Block G; Stauffer L; Lines C
    Br J Clin Pharmacol; 1995 Mar; 39(3):333-6. PubMed ID: 7619678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
    Hsu I; Spinler SA; Johnson NE
    Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of pravastatin and lovastatin on nighttime sleep and daytime performance.
    Roth T; Richardson GR; Sullivan JP; Lee RM; Merlotti L; Roehrs T
    Clin Cardiol; 1992 Jun; 15(6):426-32. PubMed ID: 1617822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of pravastatin and lovastatin on sleep disturbance in hypercholesterolemic subjects.
    Ehrenberg BL; Lamon-Fava S; Corbett KE; McNamara JR; Dallal GE; Schaefer EJ
    Sleep; 1999 Feb; 22(1):117-21. PubMed ID: 9989373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteins.
    Richter WO; Jacob BG; Schwandt P
    Int J Tissue React; 1991; 13(2):107-10. PubMed ID: 1955291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter comparative trial of lovastatin and pravastatin in the treatment of hypercholesterolemia. The Lovastatin Pravastatin Study Group.
    Am J Cardiol; 1993 Apr; 71(10):810-5. PubMed ID: 8456759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment (2 years) with the HMG CoA reductase inhibitors lovastatin or pravastatin in combination with cholestyramine in patients with severe primary hypercholesterolemia.
    Jacob BG; Richter WO; Schwandt P
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):396-400. PubMed ID: 7504129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors.
    Mortensen SA; Leth A; Agner E; Rohde M
    Mol Aspects Med; 1997; 18 Suppl():S137-44. PubMed ID: 9266515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the short-term efficacy and tolerability of lovastatin and pravastatin in the management of primary hypercholesterolemia.
    McPherson R; Bedard J; Connelly P; Curnew G; Davignon J; Echenberg D; Lavin P; Leiter L; Lenis J; McQueen M
    Clin Ther; 1992; 14(2):276-91. PubMed ID: 1611649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolaemia.
    Eckernäs SA; Roos BE; Kvidal P; Eriksson LO; Block GA; Neafus RP; Haigh JR
    Br J Clin Pharmacol; 1993 Mar; 35(3):284-9. PubMed ID: 8471404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects on quality of life and of the efficacy and tolerability of lovastatin versus pravastatin. The Quality of Life Multicenter Group.
    Weir MR; Berger ML; Weeks ML; Liss CL; Santanello NC
    Am J Cardiol; 1996 Mar; 77(7):475-9. PubMed ID: 8629587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do cholesterol-lowering agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers.
    Harrison RW; Ashton CH
    Br J Clin Pharmacol; 1994 Mar; 37(3):231-6. PubMed ID: 8198930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lovastatin on cognitive function and psychological well-being.
    Muldoon MF; Barger SD; Ryan CM; Flory JD; Lehoczky JP; Matthews KA; Manuck SB
    Am J Med; 2000 May; 108(7):538-46. PubMed ID: 10806282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
    Plans-Rubió P
    Am J Cardiovasc Drugs; 2006; 6(3):177-88. PubMed ID: 16780391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pravastatin in the treatment of primary hypercholesterolemia: a Swiss multicenter study].
    Ferrari P; Weidmann P; Riesen WF; Martius F; Luban S; Pasotti E; Erne P; Fragiacomo C; Noseda G; Reutter F
    Schweiz Med Wochenschr; 1993 Sep; 123(37):1736-41. PubMed ID: 8211024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.